From Blue Lion Musings on TG

đźš© The antiviral drug remdesivir, brand name Veklury, is approved for use against COVID-19 despite research showing it lacks effectiveness and can cause high rates of organ failure.

🚩 A study published in The Lancet found “no clinical benefit” from the use of remdesivir in hospitalized patients.

đźš© The U.S. government pays hospitals a 20% upcharge on the entire hospital bill when remdesivir is used.

If the jab doesn’t kill you, there’s remdesivir.

Only people mentioned by @JVBanon in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from JVBanon nonaBVJ, click on at the bottom under it